Related Experiment Video
Updated: Mar 18, 2026

Improved Renal Denervation Mitigated Hypertension Induced by Angiotensin II Infusion
Published on: May 26, 2022
Insights
Most hypertension patients in the US stop treatment within 5 years. Improved patient education on disease, treatment, and outcomes can significantly reduce this high dropout rate.
Area of Science:
- Cardiovascular Medicine
- Public Health
Background:
- Recent studies indicate a significant 5-year treatment abandonment rate among hypertensive patients in the United States.
- This high dropout rate is not attributed to adverse effects of prescribed therapies.
Purpose of the Study:
- To investigate the primary reasons for treatment non-adherence in hypertensive patients.
- To identify strategies for improving long-term patient engagement in hypertension management.
Main Methods:
- Analysis of data from two recent publications on patient adherence.
- Qualitative assessment of patient-reported reasons for discontinuing treatment.
Main Results:
- The majority of hypertensive patients abandon treatment within 5 years.
- Patients frequently cited lack of adequate information regarding their condition and treatment protocols as the main reason for cessation.
- Side effects were not identified as a primary cause for abandonment.
Conclusions:
- Enhancing patient and family understanding of hypertension, treatment plans, expected results, and potential side effects is crucial.
- Improved patient education is a key strategy to markedly decrease treatment dropout rates in hypertension management.
Abstract:
Two recent publications have demonstrated that, in the United States, most hypertensive patients are lost to treatment by 5 years. This high percentage of abandonment is not caused by side effects of the prescribed therapy; most patients claimed they stopped the treatment because they were not correctly informed about the nature of their disease and the way the treatment had to be carried out. The frequency of drop-out may be markedly decreased if the hypertensive patient or his family has a good understanding of the disease, and correct information about the treatment and the expected results, as well as the possible side effects.
Related Concept Videos
Heart Failure Drugs: Inhibitors of Renin-Angiotensin System
Hypertension IV: Drug Therapy and Lifestyle Modifications
Antihypertensive Drugs: Action of Diuretics
Antihypertensive Drugs: Potassium-Sparing Diuretics
Treatment for Pulmonary Arterial Hypertension: Endothelin Receptor Antagonists
ETs are synthesized through a complex sequence of enzymatic steps, primarily involving an enzyme referred to as endothelin-converting enzyme...
Antihypertensive Drugs: Angiotensin II Receptor Blockers

